GPC3 and hepatocellular carcinoma: NKCEs such as ISB1442 (117), CYT-338 (94), and CYT-303 (95) have also been reported to effectively induce CDC against CD38+ lymphoma cells and GPC-3+ hepatocellular carcinoma cells.